Performance of the cobas EZH2 mutation test on clinical samples from non-Hodgkin lymphoma patients
Päätekijät: | Johnny Y. Shyu, Peter A. Schlag, Sylwia M. Karwowska, Chitra F. Manohar, Huan M. Truong, John W. Longshore, Guili Zhang |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Public Library of Science (PLoS)
2023-01-01
|
Sarja: | PLoS ONE |
Linkit: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721068/?tool=EBI |
Samankaltaisia teoksia
-
Agile design and development of a high throughput cobas SARS-CoV-2 RT-PCR diagnostic test
Tekijä: Chitra Manohar, et al.
Julkaistu: (2022-09-01) -
Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin’s lymphoma and T-cell non-Hodgkin’s lymphoma
Tekijä: Maria Kleppe, et al.
Julkaistu: (2011-11-01) -
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.
Tekijä: Sarah K Knutson, et al.
Julkaistu: (2014-01-01) -
EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
Tekijä: C. Martínez-Laperche, et al.
Julkaistu: (2022-09-01) -
Cobas 4800 HPV detection in cervical samples of Polish women
Tekijä: Beata Smolarz, et al.
Julkaistu: (2019-06-01)